SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-22-012045
Filing Date
2022-08-04
Accepted
2022-08-04 07:18:41
Documents
61
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20220630x6k.htm 6-K 21344
2 EX-99.1 tmb-20220630xex99d1.htm   iXBRL EX-99.1 890987
3 EX-99.2 tmb-20220630xex99d2.htm EX-99.2 517083
  Complete submission text file 0001558370-22-012045.txt   4193513

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20220630.xsd EX-101.SCH 48509
5 EX-101.CAL tmb-20220630_cal.xml EX-101.CAL 42589
6 EX-101.DEF tmb-20220630_def.xml EX-101.DEF 133019
7 EX-101.LAB tmb-20220630_lab.xml EX-101.LAB 303130
8 EX-101.PRE tmb-20220630_pre.xml EX-101.PRE 223843
55 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220630xex99d1_htm.xml XML 473844
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 221134665
SIC: 2834 Pharmaceutical Preparations